These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
313 related articles for article (PubMed ID: 18810612)
1. Role of TGF-Beta in the induction of Foxp3 expression and T regulatory cell function. Shevach EM; Davidson TS; Huter EN; Dipaolo RA; Andersson J J Clin Immunol; 2008 Nov; 28(6):640-6. PubMed ID: 18810612 [TBL] [Abstract][Full Text] [Related]
2. CD4+ FoxP3+ regulatory T cells confer infectious tolerance in a TGF-beta-dependent manner. Andersson J; Tran DQ; Pesu M; Davidson TS; Ramsey H; O'Shea JJ; Shevach EM J Exp Med; 2008 Sep; 205(9):1975-81. PubMed ID: 18710931 [TBL] [Abstract][Full Text] [Related]
3. Critical Role of TGF-β and IL-2 Receptor Signaling in Foxp3 Induction by an Inhibitor of DNA Methylation. Freudenberg K; Lindner N; Dohnke S; Garbe AI; Schallenberg S; Kretschmer K Front Immunol; 2018; 9():125. PubMed ID: 29456534 [TBL] [Abstract][Full Text] [Related]
4. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. Chen W; Jin W; Hardegen N; Lei KJ; Li L; Marinos N; McGrady G; Wahl SM J Exp Med; 2003 Dec; 198(12):1875-86. PubMed ID: 14676299 [TBL] [Abstract][Full Text] [Related]
5. Activin a promotes the TGF-beta-induced conversion of CD4+CD25- T cells into Foxp3+ induced regulatory T cells. Huber S; Stahl FR; Schrader J; Lüth S; Presser K; Carambia A; Flavell RA; Werner S; Blessing M; Herkel J; Schramm C J Immunol; 2009 Apr; 182(8):4633-40. PubMed ID: 19342638 [TBL] [Abstract][Full Text] [Related]
6. Rapid suppression of cytokine transcription in human CD4+CD25 T cells by CD4+Foxp3+ regulatory T cells: independence of IL-2 consumption, TGF-beta, and various inhibitors of TCR signaling. Oberle N; Eberhardt N; Falk CS; Krammer PH; Suri-Payer E J Immunol; 2007 Sep; 179(6):3578-87. PubMed ID: 17785792 [TBL] [Abstract][Full Text] [Related]
7. A dynamic dual role of IL-2 signaling in the two-step differentiation process of adaptive regulatory T cells. Guo Z; Khattar M; Schroder PM; Miyahara Y; Wang G; He X; Chen W; Stepkowski SM J Immunol; 2013 Apr; 190(7):3153-62. PubMed ID: 23427250 [TBL] [Abstract][Full Text] [Related]
8. Foxp3 expression is required for the induction of therapeutic tissue tolerance. Regateiro FS; Chen Y; Kendal AR; Hilbrands R; Adams E; Cobbold SP; Ma J; Andersen KG; Betz AG; Zhang M; Madhiwalla S; Roberts B; Waldmann H; Nolan KF; Howie D J Immunol; 2012 Oct; 189(8):3947-56. PubMed ID: 22988034 [TBL] [Abstract][Full Text] [Related]
9. A kinetic and dynamic analysis of Foxp3 induced in T cells by TGF-beta. Selvaraj RK; Geiger TL J Immunol; 2007 Jul; 179(2):11 p following 1390. PubMed ID: 17695668 [TBL] [Abstract][Full Text] [Related]
10. IL-2 controls the stability of Foxp3 expression in TGF-beta-induced Foxp3+ T cells in vivo. Chen Q; Kim YC; Laurence A; Punkosdy GA; Shevach EM J Immunol; 2011 Jun; 186(11):6329-37. PubMed ID: 21525380 [TBL] [Abstract][Full Text] [Related]
11. TGF-β-Induced Regulatory T Cells Directly Suppress B Cell Responses through a Noncytotoxic Mechanism. Xu A; Liu Y; Chen W; Wang J; Xue Y; Huang F; Rong L; Lin J; Liu D; Yan M; Li QZ; Li B; Song J; Olsen N; Zheng SG J Immunol; 2016 May; 196(9):3631-41. PubMed ID: 27001954 [TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-beta and all-trans retinoic acid generate ex vivo transgenic regulatory T cells with intestinal homing receptors. Moore C; Sauma D; Morales J; Bono MR; Rosemblatt M; Fierro JA Transplant Proc; 2009; 41(6):2670-2. PubMed ID: 19715998 [TBL] [Abstract][Full Text] [Related]
13. [Main regulatory factors for differentiation, development and function of naturally occurred CD4+ CD25+ regulatory T cells]. Wu M; Xue YH Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Feb; 16(1):207-12. PubMed ID: 18315933 [TBL] [Abstract][Full Text] [Related]
14. Selective expansion of foxp3-positive regulatory T cells and immunosuppression by suppressors of cytokine signaling 3-deficient dendritic cells. Matsumura Y; Kobayashi T; Ichiyama K; Yoshida R; Hashimoto M; Takimoto T; Tanaka K; Chinen T; Shichita T; Wyss-Coray T; Sato K; Yoshimura A J Immunol; 2007 Aug; 179(4):2170-9. PubMed ID: 17675476 [TBL] [Abstract][Full Text] [Related]
16. Ex vivo IL-1 receptor type I expression in human CD4+ T cells identifies an early intermediate in the differentiation of Th17 from FOXP3+ naive regulatory T cells. Raffin C; Raimbaud I; Valmori D; Ayyoub M J Immunol; 2011 Nov; 187(10):5196-202. PubMed ID: 21998454 [TBL] [Abstract][Full Text] [Related]
17. C6-ceramide in combination with transforming growth factor-β enhances Treg cell differentiation and stable FoxP3 expression in vitro and in vivo. Kue CS; Lim HX; Jung MY; Hong HJ; Cho D; Kim TS Immunobiology; 2013 Jul; 218(7):952-9. PubMed ID: 23313049 [TBL] [Abstract][Full Text] [Related]
19. Cutting edge: OX40 inhibits TGF-beta- and antigen-driven conversion of naive CD4 T cells into CD25+Foxp3+ T cells. So T; Croft M J Immunol; 2007 Aug; 179(3):1427-30. PubMed ID: 17641007 [TBL] [Abstract][Full Text] [Related]
20. Identification and characterization of Foxp3(+) gammadelta T cells in mouse and human. Kang N; Tang L; Li X; Wu D; Li W; Chen X; Cui L; Ba D; He W Immunol Lett; 2009 Aug; 125(2):105-13. PubMed ID: 19539651 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]